Apria, Inc. (NYSE:APR) EVP Mark E. Litkovitz sold 2,458 shares of the business’s stock in a transaction dated Monday, October 11th. The shares were sold at an average price of $32.40, for a total transaction of $79,639.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of NYSE:APR traded down $0.02 during trading on Wednesday, reaching $32.41. 186,567 shares of the stock were exchanged, compared to its average volume of 319,229. The company has a debt-to-equity ratio of 215.95, a quick ratio of 1.18 and a current ratio of 1.21. Apria, Inc. has a 12-month low of $20.07 and a 12-month high of $40.00. The firm has a market cap of $1.14 billion and a price-to-earnings ratio of 0.69. The firm’s 50-day moving average price is $35.46 and its 200 day moving average price is $31.20.
Apria (NYSE:APR) last issued its earnings results on Thursday, August 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.17. The firm had revenue of $286.28 million for the quarter, compared to analysts’ expectations of $280.18 million. As a group, equities research analysts forecast that Apria, Inc. will post 1.63 EPS for the current year.
Large investors have recently modified their holdings of the company. Bank of New York Mellon Corp grew its holdings in shares of Apria by 24.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,628,284 shares of the company’s stock worth $45,593,000 after purchasing an additional 320,425 shares during the period. Northern Trust Corp purchased a new position in Apria in the 1st quarter worth approximately $2,404,000. HBK Investments L P purchased a new position in Apria in the 1st quarter worth approximately $1,397,000. Oliver Luxxe Assets LLC purchased a new position in Apria in the 2nd quarter worth approximately $435,000. Finally, Advisor Group Holdings Inc. purchased a new position in Apria in the 2nd quarter worth approximately $240,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
Apria Company Profile
Apria, Inc provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products.
Recommended Story: How do investors use RSI to grade stocks?
Receive News & Ratings for Apria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apria and related companies with MarketBeat.com's FREE daily email newsletter.